Schedule 13G ownership disclosure
CAN-FITE BIOPHARMA LTD
Security class unavailable · CUSIP: 13471N102
Event date: 2014-12-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,080,664
- Percent of class
- 5.0700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-14-004522
- Form type
- SC 13G
- Filer
- Can-Fite BioPharma Ltd.
- CIK
- CIK 1536196
- Filed
- Dec 05, 2014
- Reporting period
- Dec 02, 2014
- Description
- Schedule 13G beneficial ownership